Bring the power of Foundation Medicine and Roche into your lab.

How can the AVENIO Tumor Tissue CGP Kit accelerate your oncology research to help advance the future of patient care? 

As the genomic landscape of cancer continues to expand, our new AVENIO assay provides access to an increasing range of reliable genomic alterations and insights about solid tumours with results in just 5 days.*

2004 1 Single Biomarker
2014 2 Hotsot Panels
2017 3 CGP

How does it work?

The AVENIO Tumor Tissue CGP Kit is available now to support your solid tumour oncology research. Built on the proven expertise of FoundationOne® CDx technology, the kit enables you to analyse a panel of over 300 relevant genes by comprehensive profiling in a single in-house test, offering fast results and flexible solutions.5,6 The broad panel of genes provides superior coverage of clinically relevant genomic alterations within the tumour genome, identifying many alterations at one time.

Single in-house test
Analyse >300 genes
Results in 5 days*
Bioinformatics platform

The AVENIO Tumor Tissue CGP Kit generates genomic insights from sample to result in your lab in just 5 days.*

What do the results show?

Post-sequencing, you can analyse samples with ease and access critical genomic information using the Foundation Medicine Analysis Software. Take advantage of Roche and Foundation Medicine's knowledgebase, built-in quality control metrics, and multi-variable models to explore deeper genomic insights and accelerate your oncology research. The FoundationOne® Analysis Platform for bioinformatics provides key information including over 500,000 genomic alteration profiles along with tumour mutational burden (TMB), microsatellite instability (MSI), and loss of heterozygosity (LoH) and over 500 publications to support your analysis and get the best out of CGP testing.   

Get deeper genomic insights about solid tumours in your lab. Order your kit today!

Foundation Medicine also provides services in CGP for solid tumour, liquid and blood samples, allowing you to gain insights needed to accelerate progress in precision medicine. To find out more about how you can use Foundation Medicine services, click on the button below.

*Results received within just 5 days from sample extraction to variant calling.

CGP, comprehensive genomic profiling. 


1. Pao W et al. Lancet Oncol 2011; 12: 175–80.
2. Sholl LM et al. J Thorac Oncol 2015; 10: 768–77.
3. Kris MG et al. JAMA 2014; 311: 1998–2006.
4. Jordan EJ et al. Cancer Discov 2017; 7: 596–609.
5. FoundationOne® CDx Technical Specifications, 2019. Available at: https://www.foundationmedicine.qarad.eifu.online/foundationmedicine/en/foundationmedicine  (Accessed September 2021).
6. FoundationOne® Liquid CDx Technical Specifications, 2020. Available at: https://www.foundationmedicine.qarad.eifu.online/foundationmedicine/en/foundationmedicine  (Accessed September 2021).